Measles, Mumps, Rubella (MMR) Immunity Profile
Synonyms
- MMR Antibodies
Test Includes
Measles IgG antibodies; Mumps IgG antibodies; Rubella IgG antibodies
Expected Turnaround Time
1 - 2 days
Turnaround time is defined as the usual number of days from the date of pickup of a specimen for testing to when the result is released to the ordering provider. In some cases, additional time should be allowed for additional confirmatory or additional reflex tests. Testing schedules may vary.
Related Documents
Specimen Requirements
Specimen
Serum
Volume
2 mL
Minimum Volume
1 mL
Container
Red-top tube or gel-barrier tube
Storage Instructions
Refrigerate
Causes for Rejection
Hemolysis; lipemia; gross bacterial contamination
Test Details
Use
Aid in the determination of serological status to measles, mumps, and rubella viruses. A positive result generally indicates exposure to virus or previous vaccination. A positive result is considered adequate laboratory evidence of immunity.
Methodology
See individual tests.
Reference Interval
See individual tests.
Additional Information
Measles
Acceptable presumptive evidence of Measles Immunity (at least one of the following):
• Documentation of age-appropriate vaccination against measles virus.
• Laboratory evidence of immunity (IgG in serum; equivocal results should be considered negative).
• Laboratory confirmation of measles.
• Birth before 1957.
Persons who have measles-specific IgG antibody that is detectable by any commonly used serological assay are considered to have adequate laboratory evidence of measles immunity. Persons with an equivocal serologic test result do not have adequate presumptive evidence of immunity and should be considered susceptible unless they have other evidence of measles immunity.
Documented age-appropriate vaccination supersedes the results of subsequent serologic testing. If a person who has two documented doses of measles-containing vaccine is tested serologically and is determined to have negative or equivocal measles results, it is not recommended that the person receive an additional dose of vaccine. Such persons should be considered to have presumptive evidence of immunity.
Mumps
Acceptable presumptive evidence of Mumps Immunity (at least one of the following):
• Documentation of age-appropriate vaccination against mumps virus.
• Laboratory evidence of immunity (IgG in serum; equivocal results should be considered negative).
• Laboratory confirmation of disease.
• Born before 1957.
Rubella
Acceptable presumptive evidence of Rubella Immunity (at least one of the following):
• Documentation of 1-dose of live rubela virus-containing vaccine.
• Laboratory evidence of immunity (IgG in serum; equivocal results should be considered negative).
• Laboratory confirmation of disease.
• Born before 1957 (except women of childbearing age who could become pregnant).
References
LOINC® Map
| Order Code | Order Code Name | Order Loinc | Result Code | Result Code Name | UofM | Result LOINC |
|---|---|---|---|---|---|---|
| 058495 | Measles/Mumps/Rubella Immunity | 92929-9 | 006204 | Rubella Antibodies, IgG | index | 5334-8 |
| 058495 | Measles/Mumps/Rubella Immunity | 92929-9 | 096564 | Measles Antibodies, IgG | AU/mL | 5244-9 |
| 058495 | Measles/Mumps/Rubella Immunity | 92929-9 | 096554 | Mumps Abs, IgG | AU/mL | 25418-5 |
© 2021 Laboratory Corporation of America® Holdings and Lexi-Comp Inc. All Rights Reserved.
CPT Statement/Profile Statement
The LOINC® codes are copyright © 1994-2021, Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. Permission is granted in perpetuity, without payment of license fees or royalties, to use, copy, or distribute the LOINC® codes for any commercial or non-commercial purpose, subject to the terms under the license agreement found at https://loinc.org/license/. Additional information regarding LOINC® codes can be found at LOINC.org, including the LOINC Manual, which can be downloaded at LOINC.org/downloads/files/LOINCManual.pdf